Skip to main content
Springer logoLink to Springer
. 2020 Apr 7;24(5):402–403. doi: 10.1007/s10157-020-01883-y

Correction to: A nationwide survey on clinical practice patterns and bleeding complications of percutaneous native kidney biopsy in Japan

Takehiko Kawaguchi 1,, Tasuku Nagasawsa 2, Kazuhiko Tsuruya 3, Kenichiro Miura 4, Takayuki Katsuno 5, Takashi Morikawa 6, Eiji Ishikawa 7, Masao Ogura 8, Hideki Matsumura 9, Ryota Kurayama 10, Shinsuke Matsumoto 11, Yuhji Marui 12, Shigeo Hara 13, Shoichi Maruyama 14, Ichiei Narita 15, Hirokazu Okada 16, Yoshifumi Ubara 17; Committee of Practical Guide for Kidney Biopsy 2019
PMCID: PMC7645429  PMID: 32266636

Correction to: Clinical and Experimental Nephrology 10.1007/s10157-020-01869-w

In the original publication, some errors have been found in the alignment of Table 9. The corrected table is given below

Table 9.

Biopsy procedures and timing of bleeding after biopsy for patients undergoing transcatheter arterial embolization (TAE)

Biopsy procedures (%)
Needle gauge 14 8
15 62
16 3
17 27
Needle passes for sampling specimens 1 3
2 32
3 35
4 14
≥ 5 16
Use of hemostatic agents Yes 57
No 43
Manual compression on the biopsy site after biopsy < 15 min 61
15–30 min 31
≥ 30 min 8
Strict bed rest in a supine position after biopsy < 2 h 26
2–4 h 28
4–8 h 30
8–12 h 13
≥ 12 h 3
Total bed rest after biopsy < 8 h 13
8–16 h 30
16–24 h 48
≥ 24 h 8
Number of kidney biopsies the operators had experienced before the biopsy for the patient with TAE < 50 32
50–200 39
≥ 200 29
Timing of bleeding requiring TAE after biopsy (%)
Cumulative timing of bleeding < 6 h 53
< 12 h 60
< 24 h 65
< 7 days 80
≥ 7 days 20

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Clinical and Experimental Nephrology are provided here courtesy of Springer

RESOURCES